Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Alibaba Health Information Technology Debt-to-EBITDA?
Alibaba Health Information TechnologyALBHF 51 Debt-to-EBITDA is 0.03 as of Mar. 2026, which is at its 10-year median of 0.03. GuruFocus rates ALBHF with a GF Scoreâ„¢ of 51/100 and a GF Valueâ„¢ of $0.64 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 97.7% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
ALBHF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -58.87 Med: 0.03 Max: 0.96
Current: 0.03
During the past 13 years, the highest Debt-to-EBITDA Ratio of Alibaba Health Information Technology was 0.96. The lowest was -58.87. And the median was 0.03.
ALBHF's Debt-to-EBITDA is ranked better than 97.7% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.21
vs ALBHF: 0.03
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Alibaba Health Information Technology Debt-to-EBITDA Related Terms
Alibaba Health Information Technology Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Debt-to-EBITDA Chart
Alibaba Health Information Technology Debt-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Alibaba Health Information Technology (ALBHF) has a Debt-to-EBITDA of 0.03 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Alibaba Health Information Technology. This is near median its historical median of 0.03. According to the industry distribution chart, Alibaba Health Information Technology ranks #11 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 2.3%.
Is Alibaba Health Information Technology's Debt-to-EBITDA too high?
Alibaba Health Information Technology's current Debt-to-EBITDA of 0.03 is near median its 10-year median of 0.03. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.21. Alibaba Health Information Technology's value of 0.03 is 98.6% below this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #11 out of 478 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Debt-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #11 out of 478 companies for Debt-to-EBITDA. This places Alibaba Health Information Technology in the top 2% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.21. Alibaba Health Information Technology's value of 0.03 is 98.6% below this benchmark. While the company's 10-year median is 0.03 vs. the industry median of 2.21, Alibaba Health Information Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.21, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Debt-to-EBITDA of 0.03 is 98.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Alibaba Health Information Technology. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Debt-to-EBITDA is 0.03, which is near median its own 10-year median of 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.64, compared to a current price of $0.44 — trading 31.4% below its estimated fair value. The current Debt-to-EBITDA is 0.03, which is near median its 10-year median of 0.03 and 98.6% below the Healthcare Providers & Services industry median of 2.21. Alibaba Health Information Technology's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Debt-to-EBITDA is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.44 is trading 31.4% below its estimated GF Value™ of $0.64.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
Debt-to-EBITDA: 0.03 (near median its 10-year median of 0.03)
GF Value™: $0.64 vs. price of $0.44 (31.4% below fair value)
Industry Position: 98.6% below the Healthcare Providers & Services median (#11 of 478)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
51GF Score
Get the complete analysis for ALBHF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
